This Event is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.

Key Event: 1757

Key Event Title

A descriptive phrase which defines a discrete biological change that can be measured. More help

Decrease, Sperm count

Short name
The KE short name should be a reasonable abbreviation of the KE title and is used in labelling this object throughout the AOP-Wiki. More help
Decrease, Sperm count
Explore in a Third Party Tool

Biological Context

Structured terms, selected from a drop-down menu, are used to identify the level of biological organization for each KE. More help
Level of Biological Organization
Individual

Event Components

The KE, as defined by a set structured ontology terms consisting of a biological process, object, and action with each term originating from one of 14 biological ontologies (Ives, et al., 2017; https://aopwiki.org/info_pages/2/info_linked_pages/7#List). Biological process describes dynamics of the underlying biological system (e.g., receptor signalling).Biological process describes dynamics of the underlying biological system (e.g., receptor signaling).  The biological object is the subject of the perturbation (e.g., a specific biological receptor that is activated or inhibited). Action represents the direction of perturbation of this system (generally increased or decreased; e.g., ‘decreased’ in the case of a receptor that is inhibited to indicate a decrease in the signaling by that receptor).  Note that when editing Event Components, clicking an existing Event Component from the Suggestions menu will autopopulate these fields, along with their source ID and description.  To clear any fields before submitting the event component, use the 'Clear process,' 'Clear object,' or 'Clear action' buttons.  If a desired term does not exist, a new term request may be made via Term Requests.  Event components may not be edited; to edit an event component, remove the existing event component and create a new one using the terms that you wish to add.  Further information on Event Components and Biological Context may be viewed on the attached pdf. More help

Key Event Overview

AOPs Including This Key Event

All of the AOPs that are linked to this KE will automatically be listed in this subsection. This table can be particularly useful for derivation of AOP networks including the KE.Clicking on the name of the AOP will bring you to the individual page for that AOP. More help
AOP Name Role of event in AOP Point of Contact Author Status OECD Status
Alkylation of DNA leading to decreased sperm count AdverseOutcome Carole Yauk (send email) Under development: Not open for comment. Do not cite
Inhibition CYP26B1 in fetal testis leads to reduced fertility KeyEvent Terje Svingen (send email) Under development: Not open for comment. Do not cite
OUVFs and PTP AOP pathways in reproductive toxicity KeyEvent Nataraj Bojan (send email) Under development: Not open for comment. Do not cite

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) that help to define the biological applicability domain of the KE.In many cases, individual species identified in these structured fields will be those for which the strongest evidence used in constructing the AOP was available in relation to this KE. More help

Life Stages

An indication of the the relevant life stage(s) for this KE. More help

Sex Applicability

An indication of the the relevant sex for this KE. More help

Key Event Description

A description of the biological state being observed or measured, the biological compartment in which it is measured, and its general role in the biology should be provided. More help

Sperm is produced in the seminiferous tubules of the testis through spermatogenesis (Sharma & Agarwal, 2011). This process begins with Type A spermatogonia, which divide by mitosis to maintain the stem cell pool. A subset of these cells differentiate into Type B spermatogonia, which divide by mitosis and give rise to primary spermatocytes. Subsequently, primary spermatocytes undergo meiosis I to form secondary spermatocytes, which undergo meiosis II to produce haploid spermatids. Spermatids then differentiate into spermatozoa through spermiogenesis, a process marked by several morphological changes, including condensation and elongation of the nucleus, acrosome formation, and development of the flagellum (Nishimura & L’Hernault, 2017; Sharma & Agarwal, 2011). Spermatozoa are released into the seminiferous tubule lumen, exit the testis through the rete testis, and enter the epididymis, where sperm maturation occurs. Spermatozoa acquire motility and acrosomal function during transit through the three distinct regions of the epididymis: caput, corpus, and cauda (Sharma & Agarwal, 2011).

Sperm count refers to the number of spermatids present in the testis, or the number of spermatozoa present in semen or the cauda epididymis. Reduced sperm count describes a decrease in spermatids or spermatozoa with respect to a control or reference number. In humans, a total sperm number below 39 million per ejaculate and a sperm concentration below 16 million per ml represent the fifth percentile lower limits, based on a reference group of men whose partners conceived within 12 months (World Health Organization, 2021). Reduced sperm count can be temporary, prolonged, or permanent depending on the cause, including genetic or other intrinsic problems, or an exposure that occurred during development that impaired the stem cell pool.

The toxicological interpretation of reduced sperm count depends on the biological compartment assessed. A decrease in testicular spermatid number suggests impairment of one or more stages of spermatogenesis (Creasy & Chapin, 2013; M. L. Meistrich, 1989). However, a reduction in cauda epididymal sperm reserves may reflect impaired spermatogenesis or spermatid retention in the testis, disruption of epididymal processes such as sperm transit, maturation, and storage, or a combination of these effects (Blazak et al., 1985; Creasy & Chapin, 2013).

The timing and duration of exposure are important considerations when evaluating sperm count due to the length of spermatogenesis and the spermatogenic cycle. Exposure durations spanning multiple spermatogenic cycles may be necessary to produce detectable changes in sperm count, as toxicants that target earlier stages of spermatogenesis may only affect sperm count after the damaged cells have progressed through subsequent stages of development (Amann, 1986; Mangelsdorf et al., 2003). For epididymal sperm counts, sperm transit time through the epididymis should also be considered.

How It Is Measured or Detected

A description of the type(s) of measurements that can be employed to evaluate the KE and the relative level of scientific confidence in those measurements.These can range from citation of specific validated test guidelines, citation of specific methods published in the peer reviewed literature, or outlines of a general protocol or approach (e.g., a protein may be measured by ELISA). Do not provide detailed protocols. More help

OECD Test Guideline 416: Two-Generation Reproduction Toxicity, and OECD Test Guideline 443: Extended One-Generation Reproductive Toxicity Study, recommend estimating sperm count by quantifying cauda epididymis sperm reserves and spermatids in the testis (OECD, 2001, 2025).

Sperm counts can be estimated from the testis, epididymis, or semen. Testicular sperm counts are generally estimated by quantifying homogenization-resistant spermatids (Amann, 1986). During spermiogenesis, spermatid nuclei become highly condensed and resistant to mechanical or biochemical breakdown. Homogenization destroys most testicular cells and nuclei except for the late-stage spermatid nuclei, which can then be quantified (Amann, 1986). Testicular sperm counts can also be used to estimate daily sperm production (DSP) by dividing the number of homogenization-resistant spermatid nuclei by the number of days they spend in the testis (Amann, 1981).

Epididymal sperm counts are most often estimated using the cauda epididymis, where sperm is stored (Seed et al., 1996). Sperm can be isolated from the cauda epididymis using various methods, including diffusion, aspiration, or homogenization (Chapin et al., 1992; Seed et al., 1996; Slott et al., 1991). In the diffusion method, small incisions are made in the cauda epididymis to allow sperm to swim out into the surrounding medium. The aspiration method collects sperm directly from incised tissue using a capillary tube. Homogenization methods mechanically disrupt epididymal tissue to release sperm (Amann, 1986; Seed et al., 1996).

In species where semen can be collected, such as humans, dogs, and rabbits, sperm count can be evaluated from ejaculated semen samples (Seed et al., 1996).

The resulting sperm suspension is counted manually or by automated methods. Manual counting using a hemacytometer and phase-contrast microscopy is a widely used and accepted method for determining sperm count (Amann, 1986; Seed et al., 1996; Strader et al., 1996). Sperm counting with a hemacytometer, specifically the improved Neubauer hemacytometer, is considered the gold standard and is extensively described in the WHO laboratory manual for the examination and processing of human semen (World Health Organization, 2021). Hemacytometer counts are used for calibrating other automated techniques (Kuster, 2005; Prathalingam et al., 2006).

Automated methods include Computer-Assisted Sperm Analysis (CASA), in which a video camera attached to a microscope captures images or videos that are analyzed by specialized software (Akal, 2023). The CASA system objectively estimates sperm concentration and related sperm parameters. CASA-derived sperm counts have demonstrated strong agreement with hemacytometer-based methods while improving analytical efficiency (Dearing et al., 2014; Lammers et al., 2014; Strader et al., 1996). However, CASA systems have been reported to overestimate sperm count at lower concentrations due to misclassification of debris as sperm (Dearing et al., 2014).

Flow cytometry-based approaches have also been developed for counting sperm and assessing sperm membrane integrity. Sperm from zebrafish testis were stained with SYBR-14, a membrane-permeable nucleic acid dye, and propidium iodide, a DNA dye that can only permeate damaged cell membranes. Fluorescence filters were used to detect stained cells, and forward scatter (FSC) and side scatter (SSC) were used to differentiate sperm from debris. Resulting sperm counts were comparable to those obtained from using a hemacytometer (Yang et al., 2016).

Domain of Applicability

A description of the scientific basis for the indicated domains of applicability and the WoE calls (if provided).  More help

This KE is plausibly applicable to all male animals that produce sperm through spermatogenesis.

Regulatory Significance of the Adverse Outcome

An AO is a specialised KE that represents the end (an adverse outcome of regulatory significance) of an AOP. More help

References

List of the literature that was cited for this KE description. More help

Akal, E. (2023). Evaluation of sperm counting accuracy on computer-assisted sperm analysis with GoldCyto® slides and glass slides. Frontiers in Veterinary Science, 10, 1283128. https://doi.org/10.3389/fvets.2023.1283128

Amann, R. P. (1981). A Critical Review of Methods for Evaluation of Spermatogenesis from Seminal Characteristics. Journal of Andrology, 2(1), 37–58. https://doi.org/10.1002/j.1939-4640.1981.tb00595.x

Amann, R. P. (1986). Detection of alterations in testicular and epididymal function in laboratory animals. Environmental Health Perspectives, 70, 149–158. https://doi.org/10.1289/ehp.8670149

Blazak, W. F., Ernst, T. L., & Stewart, B. E. (1985). Potential indicators of reproductive toxicity: Testicular sperm production and epididymal sperm number, transit time, and motility in Fischer 344 rats. Fundamental and Applied Toxicology, 5(6, Part 1), 1097–1103. https://doi.org/10.1016/0272-0590(85)90145-9

Chapin, R. E., Filler, R. S., Gulati, D., Heindel, J. J., Katz, D. F., Mebus, C. A., Obasaju, F., Perreault, S. D., Russell, S. R., & Schrader, S. (1992). Methods for assessing rat sperm motility. Reproductive Toxicology, 6(3), 267–273. https://doi.org/10.1016/0890-6238(92)90183-t

Creasy, D. M., & Chapin, R. E. (2013). Male Reproductive System. In Haschek and Rousseaux’s Handbook of Toxicologic Pathology (pp. 2493–2598). Academic Press. https://doi.org/10.1016/B978-0-12-415759-0.00059-5

Dearing, C. G., Kilburn, S., & Lindsay, K. S. (2014). Validation of the sperm class analyser CASA system for sperm counting in a busy diagnostic semen analysis laboratory. Human Fertility, 17(1), 37–44. https://doi.org/10.3109/14647273.2013.865843

Kuster, C. (2005). Sperm concentration determination between hemacytometric and CASA systems: Why they can be different. Theriogenology, Proceedings of the 2005 Annual Conference of the Society for Theriogenology, 64(3), 614–617. https://doi.org/10.1016/j.theriogenology.2005.05.047

Lammers, J., Splingart, C., Barrière, P., Jean, M., & Fréour, T. (2014). Double-blind prospective study comparing two automated sperm analyzers versus manual semen assessment. Journal of Assisted Reproduction and Genetics, 31(1), 35–43. https://doi.org/10.1007/s10815-013-0139-2

M. L. Meistrich. (1989). Evaluation of Reproductive Toxicity by Testicular Sperm Head Counts. 8(3), 551–567. https://doi.org/10.3109/10915818909014538

Mangelsdorf, I., Buschmann, J., & Orthen, B. (2003). Some aspects relating to the evaluation of the effects of chemicals on male fertility. Regulatory Toxicology and Pharmacology, 37(3), 356–369. https://doi.org/10.1016/S0273-2300(03)00026-6

OECD. (2001). Test No. 416: Two-Generation Reproduction Toxicity. OECD. https://doi.org/10.1787/9789264070868-en

OECD. (2025). Test No. 443: Extended One-Generation Reproductive Toxicity Study. OECD Publishing. https://doi.org/10.1787/9789264185371-en

Prathalingam, N. S., Holt, W. W., Revell, S. G., Jones, S., & Watson, P. F. (2006). The Precision and Accuracy of Six Different Methods to Determine Sperm Concentration. Journal of Andrology, 27(2), 257–262. https://doi.org/10.2164/jandrol.05112

Seed, J., Chapin, R. E., Clegg, E. D., Dostal, L. A., Foote, R. H., Hurtt, M. E., Klinefelter, G. R., Makris, S. L., Perreault, S. D., Schrader, S., Seyler, D., Sprando, R., Treinen, K. A., Veeramachaneni, D. N. R., & Wise, L. D. (1996). Methods for assessing sperm motility, morphology, and counts in the rat, rabbit, and dog: A consensus report. Reproductive Toxicology, 10(3), 237–244. https://doi.org/10.1016/0890-6238(96)00028-7

Sharma, R., & Agarwal, A. (2011). Spermatogenesis: An Overview. In A. Zini & A. Agarwal (Eds.), Sperm Chromatin: Biological and Clinical Applications in Male Infertility and Assisted Reproduction (pp. 19–44). Springer. https://doi.org/10.1007/978-1-4419-6857-9_2

Slott, V. L., Suarez, J. D., & Perreault, S. D. (1991). Rat sperm motility analysis: Methodologic considerations. Reproductive Toxicology, 5(5), 449–458. https://doi.org/10.1016/0890-6238(91)90009-5

Strader, L. F., Linder, R. E., & Perreault, S. D. (1996). Comparison of rat epididymal sperm counts by IVOS HTM-IDENT and hemacytometer. Reproductive Toxicology, 10(6), 529–533. https://doi.org/10.1016/S0890-6238(96)00140-2

World Health Organization. (2021). WHO Laboratory Manual for the Examination and Processing of Human Semen (6th ed). WHO Press.

Yang, H., Daly, J., & Tiersch, T. R. (2016). Determination of Sperm Concentration Using Flow Cytometry with Simultaneous Analysis of Sperm Plasma Membrane Integrity in Zebrafish Danio rerio. Cytometry. Part A : The Journal of the International Society for Analytical Cytology, 89(4), 350–356. https://doi.org/10.1002/cyto.a.22796